Expression
Expressed in various tissues.
Function
ID4 is one of the members of the ID gene family: "Inhibitors of DNA binding". They are transcription factors which act as transcription inhibitory proteins. They are basic helix-loop-helix (bHLH) proteins which contain the bHLH dimerization domain, but lack the DNA binding domain. They are able to form heterodimers with other bHLH proteins, but inhibit the DNA binding, inactivating the process. Since bHLH proteins act as trans-cription factors, ID genes are transcription repress-sors, modulating various functions. ID proteins play critical roles in early embryonic processes, growth, differentiation, senescence and apoptosis; they are also involved in angiogenesis. ID4 is expressed in the central nervous system. ID4 is required for G1-S transition and enhance proliferation in early cortical progenitors. On the other hand, ID4 enhances RB1 -mediated inhibition of proliferation of differenciating neurons, either by direct inter-action or through interaction with other molecules of the cell cycle machinery. Other ID genes are not redondant with ID4 during telencephalic develop-ment, supporting the idea that ID4 function is unique in this context (Yun et al., 2004) . In immature neurons with high expression of ID proteins, heterodimers of bHLH-ID prevent DNA binding and expression of differentiation associated genes. ID4 may play an important suppressive role in tumor progression, and its silencing by hyper-rmethylation favours tumorogenesis (see below).
Implicated in

B-cell acute lymphoblastic leukaemia (B-ALL) with t(6;14)(p22;q32) --> ID4 -IGH
Note ID4 was juxtaposed to the IGH enhancer, leading to ID4 overexpression. (Bellido et al., 2003; Russell et al., 2008) . Prognosis Prognosis in this disease looks fair.
Non Hodgkin lymphoma
Note ID4 promoter was found hypermethylated in folli-cular lymphomas, diffuse large B-cell lymphomas, as well as lymphoid cell lines (Hagiwara et al., 2007) .
Brain tumours
Note
In oligodendroglial tumours and glioblastomas, ID4 is expressed in neoplastic astrocytes but not in neoplastic oligodendrocytes (Liang et al., 2005) .
Breast cancer
Note Hypermethylation of ID4 promoter and ID4 mRNA suppression was found in breast cancer cell lines as well as in primary breast cancers. In one study, it was a significant risk factor for nodal metastasis (Umetani et al., 2006) . In another study, BRCA1, ER (estrogen receptor), and ID4 were found expressed in breast cancer specimens from patients with invasive carcinomas. Most of the patients who expressed BRCA1 also expressed ER, but were negative for ID4, and vice versa. BRCA1-ER and ID4 are linked in a negative correlation (Roldan et al., 2006) . Id4 regulates BRCA1 expression and may be involved in hormonedependent regulation of BRCA1 homeostasis (de Candia et al., 2004) . ID4 is constitutively expressed in the normal human mammary epithelium but is suppressed in ER-. Positive breast carcinomas and preneoplastic lesions. ER-negative carcinomas are Id4 positive (de Candia et al., 2006) . These results support a possible role of Id4 as a tumor suppressor factor in the human breast and suggest that the expression of Id4 in the mammary ductal epithelium may be regulated by estrogen (de Candia et al., 2006) .
Bladder cancer
Note ID4 is part of the 6p22.3 amplicon frequently observed in advanced stage bladder cancer. ID4, as well as E2F3 and DEK, was overexpressed in bladder cancer cell lines. This overexpression was correlated with the copy number. However, ID4 expression was equivalent in fresh cancer tissues and normal urothelium .
Gastric cancer
Note ID4 promoter is hypermethylated and showed a low level of expression in 30% of gastric adenocarci-nomas and in most gastric cancer cell lines, while it's expression was high in normal gastric mucosa. Furthermore, there was a significant association of ID4 promoter hypermethylation/ID4 down regula-tion and that of hMLH1 and microsatellite instability (Chan et al., 2003) .
Colorectal cancer
Note ID4 is silenced in colorectal cancer: Hyper-methylation was found in half of the primary colorectal cancer specimens tested (and in cell lines as well), in 3/4 of liver metastases of colorectal cancer specimens tested, but not in normal epitheliums nor in adenomas. Moreover, the methylation status was correlated with the histo-pathological grade, and hypermethylation of ID4 was identified as a significant independant risk factor of poor prognosis (Umetani et al., 2005) .
Rett syndrome
Note A significantly increased protein expression of ID genes was found in human brain tissue of Rett syndrome patients, compared to controls (Peddada et al., 2006) . Rett syndrome is a X-linked neurodevelopmental disorder resembling autism, and due to MECP2 (Xq28) mutations in most cases, more rarely due to mutations of CDKL5 (Xp22) or, much less convaincingly, NTNG1 (1p13).
